Gambaran Umum
MannKind Corporation, based in the United States, primarily operates within the biopharmaceutical sector, focusing on the development and commercialization of therapeutic products for diseases such as diabetes. A key product of MannKind is Afrezza, an inhalable insulin that offers a distinctive mode of administration compared to traditional insulin injections, targeting a broad diabetic patient base seeking less invasive treatment options. Additionally, the company is involved in the development of novel therapeutic platforms including Technosphere, a technology designed for pulmonary drug delivery that represents a significant part of their research and development efforts. Leveraging its proprietary technology, MannKind aims to expand its portfolio and address significant unmet medical needs in various therapeutic areas.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk MannKind Corporation per 2025 Jun 30 adalah 301.74 MM.
- Nilai operating income untuk MannKind Corporation per 2025 Jun 30 adalah 72.74 MM.
- Nilai net income untuk MannKind Corporation per 2025 Jun 30 adalah 32.80 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 301.74 | 72.74 | 32.80 |
2025-03-31 | 297.60 | 78.16 | 30.12 |
2024-12-31 | 285.50 | 68.68 | 27.59 |
2024-09-30 | 267.20 | 57.25 | 21.57 |
2024-06-30 | 248.37 | 45.07 | 11.74 |
2024-03-31 | 224.60 | 30.96 | 8.49 |
2023-12-31 | 198.96 | 10.59 | -11.94 |
2023-09-30 | 176.55 | -9.36 | -31.29 |
2023-06-30 | 158.12 | -23.80 | -47.44 |
2023-03-31 | 128.40 | -50.73 | -71.20 |
2022-12-31 | 99.77 | -68.92 | -87.40 |
2022-09-30 | 76.23 | -85.13 | -97.51 |
2022-06-30 | 65.61 | -82.38 | -87.51 |
2022-03-31 | 70.00 | -66.45 | -94.01 |
2021-12-31 | 75.44 | -53.14 | -80.93 |
2021-09-30 | 81.37 | -34.22 | -79.28 |
2021-06-30 | 74.51 | -30.77 | -86.11 |
2021-03-31 | 66.34 | -27.42 | -60.83 |
2020-12-31 | 65.14 | -24.79 | -57.24 |
2020-09-30 | 62.69 | -27.05 | -45.09 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk MannKind Corporation pada 2025 Jun 30 adalah 0.11.
- laba per saham yang terdilusi untuk MannKind Corporation pada 2025 Jun 30 adalah 0.11.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | 0.11 | 0.11 |
2025-03-31 | 0.11 | 0.10 |
2024-12-31 | 0.10 | 0.10 |
2024-09-30 | 0.08 | 0.08 |
2024-06-30 | 0.04 | 0.05 |
2024-03-31 | 0.03 | 0.04 |
2023-12-31 | -0.04 | -0.04 |
2023-09-30 | -0.12 | -0.12 |
2023-06-30 | -0.18 | -0.18 |
2023-03-31 | -0.27 | -0.28 |
2022-12-31 | -0.34 | -0.34 |
2022-09-30 | -0.38 | -0.38 |
2022-06-30 | -0.35 | -0.35 |
2022-03-31 | -0.38 | -0.38 |
2021-12-31 | -0.32 | -0.32 |
2021-09-30 | -0.32 | -0.32 |
2021-06-30 | -0.36 | -0.36 |
2021-03-31 | -0.26 | -0.26 |
2020-12-31 | -0.26 | |
2020-09-30 | -0.21 | -0.21 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk MannKind Corporation per 2025 Jun 30 adalah 34.55 MM.
- Nilai cash from investing activities untuk MannKind Corporation per 2025 Jun 30 adalah 19.19 MM.
- Nilai kas dari aktivitas pendanaan untuk MannKind Corporation per 2025 Jun 30 adalah -93.36 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 34.55 | 19.19 | -93.36 |
2025-03-31 | 29.43 | -42.25 | -132.40 |
2024-12-31 | 42.51 | -96.65 | -137.27 |
2024-09-30 | 41.55 | -152.77 | 91.31 |
2024-06-30 | 40.88 | -123.06 | 93.37 |
2024-03-31 | 39.64 | -64.22 | 131.98 |
2023-12-31 | 34.09 | -1.99 | 136.61 |
2023-09-30 | 10.04 | 20.92 | -2.25 |
2023-06-30 | -26.70 | 59.81 | 17.56 |
2023-03-31 | -61.27 | 58.17 | 21.73 |
2022-12-31 | -80.68 | 4.87 | 21.39 |
2022-09-30 | -90.65 | -22.71 | 115.93 |
2022-06-30 | -77.76 | -45.07 | 95.82 |
2022-03-31 | -67.23 | -159.62 | 46.10 |
2021-12-31 | -61.71 | -151.54 | 270.27 |
2021-09-30 | -49.13 | -143.44 | 191.59 |
2021-06-30 | -47.40 | -148.43 | 194.82 |
2021-03-31 | -29.64 | -36.05 | 274.50 |
2020-12-31 | -28.13 | 15.22 | 49.85 |
2020-09-30 | -33.47 | 19.49 | 36.20 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk MannKind Corporation pada 2025 Jun 30 adalah 0.07.
- roic untuk MannKind Corporation pada 2025 Jun 30 adalah 0.23.
- croic untuk MannKind Corporation pada 2025 Jun 30 adalah -1.11.
- ocroic untuk MannKind Corporation pada 2025 Jun 30 adalah 0.22.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.07 | 0.23 | -1.11 | 0.22 | |
2025-03-31 | 0.06 | 0.37 | -2.54 | 0.56 | |
2024-12-31 | 0.05 | 0.16 | -0.15 | 0.30 | |
2024-09-30 | 0.07 | 0.09 | 0.09 | 0.31 | |
2024-06-30 | 0.03 | 0.06 | 0.75 | 0.28 | |
2024-03-31 | -0.04 | -0.09 | 1.29 | 0.26 | |
2023-12-31 | -0.24 | 0.22 | 0.08 | ||
2023-09-30 | |||||
2023-06-30 | |||||
2023-03-31 | |||||
2022-12-31 | -0.27 | -0.61 | -0.38 | -0.56 | |
2022-09-30 | |||||
2022-06-30 | -0.35 | -0.60 | -0.19 | -0.54 | |
2022-03-31 | -0.29 | -0.59 | -1.13 | -0.42 | |
2021-12-31 | -0.75 | -0.45 | 0.32 | -0.34 | |
2021-09-30 | -0.83 | -0.78 | -0.01 | -0.48 | |
2021-06-30 | -0.84 | -0.81 | -0.01 | -0.45 | |
2021-03-31 | -0.76 | -0.38 | 1.29 | -0.18 | |
2020-12-31 | -0.61 | ||||
2020-09-30 | -0.47 |
Gross Margins
- marjin kotor untuk MannKind Corporation pada 2025 Jun 30 adalah 0.75.
- marjin bersih untuk MannKind Corporation pada 2025 Jun 30 adalah 0.10.
- marjin operasi untuk MannKind Corporation pada 2025 Jun 30 adalah 0.26.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.75 | 0.10 | 0.26 |
2025-03-31 | 0.73 | 0.10 | 0.24 |
2024-12-31 | 0.72 | 0.08 | 0.21 |
2024-09-30 | 0.71 | 0.05 | 0.18 |
2024-06-30 | 0.71 | 0.04 | 0.14 |
2024-03-31 | 0.68 | -0.06 | 0.05 |
2023-12-31 | 0.66 | -0.18 | -0.05 |
2023-09-30 | -0.30 | -0.15 | |
2023-06-30 | -0.30 | -0.15 | |
2023-03-31 | -0.55 | -0.40 | |
2022-12-31 | 0.42 | -0.88 | -0.69 |
2022-09-30 | 0.00 | -1.12 | |
2022-06-30 | 0.31 | -1.33 | -1.26 |
2022-03-31 | 0.40 | -1.34 | -0.95 |
2021-12-31 | 0.48 | -1.07 | -0.71 |
2021-09-30 | 0.59 | -0.97 | -0.42 |
2021-06-30 | 0.61 | -1.16 | -0.41 |
2021-03-31 | 0.63 | -0.92 | -0.41 |
2020-12-31 | 0.62 | -0.88 | -0.38 |
2020-09-30 | 0.60 | -0.72 | -0.43 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 899460 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |